 |
Allogeneic cytomegalovirus-specific cytotoxic T lymphocytes |
|---|---|
| Trade Name | |
| Orphan Indication | Cytomegalovirus infection in patients with impaired cell-mediated immunity |
| EU Market Approval | EU |
| EU Designation Date | 2016-11-18 00:00:00 |
| Sponsor | Atara Biotherapeutics Ireland Limited |
